Main competitors
P/E (Y) Price to Book (Y) PEG (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Dividend Yield (Y) Capi.($)
-9.12x4.25x-0.24x4.07x-7.52x-7.06x-.--% 2.27B
17.76x2.02x-2.18x3.85x10.09x11.52x0.58% 68.85B
25.64x3.88x1.85x5.3x15.59x19.32x0.61% 52.13B
34.55x6.94x0.67x11.7x22.35x26.04x-.--% 43.46B
-46.16x2.53x0.35x3.26x9.62x11.22x3.31% 41.24B
24.47x1.63x-5.76x3.57x11.94x13.55x-.--% 30.41B
-7.13x4.33x-0.37x10.08x-6.19x-5.82x-.--% 24.53B
77.55x - -1.01x - - - -.--% 23.42B
64.32x5.78x0.42x6.31x43.41x48.98x-.--% 19.75B
24.47x3.59x0.02x5.19x13.62x18.87x-.--% 16.57B
-36.62x-6.49x0.89x17.52x-47.76x-54.5x-.--% 15.95B
-111.49x12182.2x2.54x11.98x-85.75x-119.56x-.--% 11.84B
17.66x - 0.2x3.62x14.01x16.36x-.--% 11.52B
46.82x - 4.33x - - - -.--% 10.46B
50.59x20.63x0.48x30.53x43.18x44.53x0.18% 9.96B
11.97x1.08x0.42x1.81x7.29x9.85x2.86% 6.28B
-46.37x - -0.83x - - - - 5.84B
61.44x4.34x-0.79x - - - - 5.83B
27.66x - 1.36x7.41x19.67x23.5x0.37% 5.64B
-108.47x - 7.19x - - - -.--% 5.33B
Average 5.98x 874.05x 0.48x 8.41x 4.24x 3.79x 0.44% 20.56B
Weighted average by Cap. 12.72x 416.56x -0.18x 7.16x 8.67x 9.63x 0.58%
Biopharmaceuticals